clinical , laboratory , genetic , and radiologic studies were evaluated for 18 patients with rheumatoid arthritis who were treated for a mean of 16.6 months with a regimen involving supplementary aspirin and piroxicam , an investigational , nonsteroidal antiinflammatory agent .
C0003873
rheumatoid arthritis
C0031990
piroxicam